NCT07398625

Brief Summary

management of CS scar ectopic pregnancy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 11, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 10, 2026

Completed
Last Updated

February 10, 2026

Status Verified

February 1, 2026

Enrollment Period

1.9 years

First QC Date

May 11, 2025

Last Update Submit

February 9, 2026

Conditions

CS Scar Pregnancy

Outcome Measures

Primary Outcomes (1)

  • irregular uterine bleeding and hematoma formation after surgical evacuation

    18 months

Interventions

ObservationOTHER

observation of cs scar pregnancy cases \&their management in Sohag University

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

1st trimester pregnancy (6-10) weeks Age: (18-40) years All types of scar ectopic pregnancy endophytic and exophytic types Viable and non-viable scar ectopic.

You may qualify if:

  • st trimester pregnancy (6-10) weeks Age: (18-40) years All types of scar ectopic pregnancy endophytic and exophytic types Viable and non-viable scar ectopic.

You may not qualify if:

  • Patients with serious systemic diseases will be excluded, such as; heart disease, thrombocytopenia, bronchial asthma and systemic lupus erythematosus because these conditions may affect treatment options and efficacy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University

Sohag, Egypt

Location

MeSH Terms

Interventions

Observation

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sohag

Study Record Dates

First Submitted

May 11, 2025

First Posted

February 10, 2026

Study Start

January 1, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

February 10, 2026

Record last verified: 2026-02

Locations

EG(1)